Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
ONCOLOGY / RESEARCH LETTER
The role of GSDMs in the immune microenvironment of prostate cancer and their impact on patient prognosis: a comprehensive analysis based on the TCGA-PRAD database
1
Department of Urology, Affiliated Hospital of Panzhihua University, Panzhihua City Hospital of Integrated Traditional Chinese and Western Medicine, Panzhihua, Sichuan Province, China
Submission date: 2024-10-14
Final revision date: 2025-01-04
Acceptance date: 2025-02-20
Online publication date: 2025-02-28
Publication date: 2025-02-28
Corresponding author
Xuhua Qiao
Department of Urology Affiliated Hospital of Panzhihua University Panzhihua City Hospital of Integrated Traditional Chinese and Western Medicine Panzhihua, Sichuan Province, China
Department of Urology Affiliated Hospital of Panzhihua University Panzhihua City Hospital of Integrated Traditional Chinese and Western Medicine Panzhihua, Sichuan Province, China
Arch Med Sci 2025;21(1):313-319
TOPICS
REFERENCES (11)
1.
Slaufova M, Karakaya T, Di Filippo M, Hennig P, Beer HD. The gasdermins: a pore-forming protein family expressed in the epidermis. Front Immunol 2023; 14: 1254150.
2.
Du T, Gao J, Li P, et al. Pyroptosis, metabolism, and tumor immune microenvironment. Clin Transl Med 2021; 11: e492.
3.
DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol 2021; 21: 785-97.
4.
Jiang J, Xu Y, Chen D, et al. Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment. Aging 2024; 16: 11683-728.
5.
Bao X, Sun M, Meng L, Zhang H, Yi X, Zhang P. Applications of pyroptosis activators in tumor immunotherapy. Mater Today Bio 2024; 28: 101191.
6.
Li M, Jiang P, Yang Y, et al. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment. Exp Hematol Oncol 2023; 12: 103.
7.
Wang H, Wang H, Chen J, Liu P, Xiao X. Overexpressed FAM111B degrades GSDMA to promote esophageal cancer tumorigenesis and cisplatin resistance. Cell Oncol 2024; 47: 343-59.
8.
Lu X, Guo T, Zhang X. Pyroptosis in cancer: friend or foe? Cancers 2021; 13: 3620.
9.
Xia XH, Yin WJ, Mao JF, et al. The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma. Am J Cancer Res 2023; 13: 1240-58.
10.
Sarrio D, Colomo S, Moreno-Bueno G. Gasdermin-B (GSDMB) takes center stage in antibacterial defense, inflammatory diseases, and cancer. FEBS J 2024; 291: 3060-71.
11.
Li L, Li Y, Bai Y. Role of GSDMB in pyroptosis and cancer. Cancer Manag Res 2020; 12: 3033-43.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
